Reduced mitotic activity at the periphery of human embryonic stem cell colonies cultured in vitro with mitotically-inactivated murine embryonic fibroblast feeder cells

被引:9
作者
Heng, BC
Cao, T
Liu, H
Rufaihah, AJ
机构
[1] Natl Univ Singapore, Fac Dent, Stem Cell Lab, Singapore 119074, Singapore
[2] Natl Univ Singapore, Fac Med, Dept Surg, Singapore 119074, Singapore
关键词
embryonic; stem cells; in vitro culture; mitosis; BrdU;
D O I
10.1002/cbf.1221
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study attempted to investigate whether different levels of mitotic activity exist within different physical regions of a human embryonic stem (hES) cell colony. Incorporation of 5-bromo-2-deoxyuridine (BrdU) within newly-synthesized DNA, followed by immunocytochemical staining was used as a means of detecting mitotically-active cells within hES colonies. The results showed rather surprisingly that the highest levels of mitotic activity are primarily concentrated within the central regions of hES colonies, whereas the peripheral regions exhibited reduced levels of cellular proliferation. Two hypothetical mechanisms are therefore proposed for hES colony growth and expansion. Firstly, it is envisaged that the less mitotically-active hES cells at the periphery of the colony are continually migrating outwards, thereby providing space for newly-divided daughter cells within the more mitotically-active central region of the hES colony. Secondly, it is proposed that the newly-divided hES cells within the central region of the colony somehow migrate to the outer periphery. This could possibly explain why the periphery of hES colonies are less mitotically-active, since there would obviously be an extended time-lag before newly-divided daughter cells are ready again for the next cell division. Further investigations need to be carried out to characterize the atypical mechanisms by which hES colonies grow and expand in size. Copyright (C) 2005 John Wiley Sons, Ltd.
引用
收藏
页码:141 / 146
页数:6
相关论文
共 10 条
[1]  
Adams DH, 1997, CELL BIOCHEM FUNCT, V15, P119, DOI 10.1002/(SICI)1099-0844(19970601)15:2<119::AID-CBF731>3.0.CO
[2]  
2-C
[3]  
Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330
[4]   Estimating average cellular turnover from 5-bromo-2′-deoxyuridine (BrdU) measurements [J].
De Boer, RJ ;
Mohri, H ;
Ho, DD ;
Perelson, AS .
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2003, 270 (1517) :849-858
[5]   Cell therapy using human embryonic stem cells [J].
Gerecht-Nir, S ;
Itskovitz-Eldor, J .
TRANSPLANT IMMUNOLOGY, 2004, 12 (3-4) :203-209
[6]   RETRACTED: Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst (Retracted Article. See vol 311, pg 335, 2006) [J].
Hwang, WS ;
Ryu, YJ ;
Park, JH ;
Park, ES ;
Lee, EG ;
Koo, JM ;
Jeon, HY ;
Lee, BC ;
Kang, SK ;
Kim, SJ ;
Ahn, C ;
Hwang, JH ;
Park, KY ;
Cibelli, JB ;
Moon, SY .
SCIENCE, 2004, 303 (5664) :1669-1674
[7]  
Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P559
[8]  
Sathananthan Henry, 2002, Reprod Biomed Online, V4, P56
[9]  
Thomson JA, 1998, SCIENCE, V282, P1827
[10]   Embryonic stem cell lines derived from human blastocysts [J].
Thomson, JA ;
Itskovitz-Eldor, J ;
Shapiro, SS ;
Waknitz, MA ;
Swiergiel, JJ ;
Marshall, VS ;
Jones, JM .
SCIENCE, 1998, 282 (5391) :1145-1147